Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

14.32
+0.06000.42%
Post-market: 14.820.5000+3.49%18:30 EDT
Volume:1.06M
Turnover:15.10M
Market Cap:1.22B
PE:-8.21
High:14.34
Open:14.21
Low:13.83
Close:14.26
52wk High:25.77
52wk Low:4.80
Shares:85.31M
Float Shares:54.48M
Volume Ratio:0.99
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7450
EPS(LYR):-0.4650
ROE:-42.66%
ROA:-21.63%
PB:2.51
PE(LYR):-30.80

Loading ...

Monte Rosa CSO Sharon Townson Disposes of Common Shares Worth $140,297.2

Reuters
·
Jul 08

Monte Rosa Therapeutics Grants Inducement Awards to New Hires, Including Options for 18,025 Shares at $24.02

Reuters
·
Jul 03

Monte Rosa Therapeutics CMO Filip Janku Disposes of 5,407 Common Shares Worth $132,471.50

Reuters
·
Jul 02

Monte Rosa Therapeutics Director Anthony M. Manning Disposes of 10,000 Common Shares Worth $231,100

Reuters
·
Jul 01

Monte Rosa Therapeutics is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 30

Guggenheim Keeps Their Buy Rating on Monte Rosa Therapeutics (GLUE)

TIPRANKS
·
Jun 30

Monte Rosa Therapeutics (GLUE) Joins Russell Growth Indexes, Is The Upside Already Priced In?

Simply Wall St.
·
Jun 30

Monte Rosa Therapeutics CSO Sharon Townson Disposes of 3,000 Common Shares for $60,000

Reuters
·
Jun 26

Wells Fargo Keeps Their Buy Rating on Monte Rosa Therapeutics (GLUE)

TIPRANKS
·
Jun 24

Monte Rosa CSO Sharon Townson disposes of 3,000 common shares worth $57,000

Reuters
·
Jun 19

Monte Rosa Therapeutics held annual shareholder meeting

Reuters
·
Jun 12

Monte Rosa CEO Markus Warmuth sells USD 106,197 of common shares

Reuters
·
Jun 03

Monte Rosa grants inducement awards to new hires, including options for 20,050 shares at USD 19.67

Reuters
·
Jun 03

Monte Rosa Therapeutics CSO Sharon Townson disposes of common shares worth $119,220

Reuters
·
Jun 02

Monte Rosa posts corporate deck spotlighting molecular glue degrader pipeline for immunology, inflammation and cancer targets

Reuters
·
Jun 01

Monte Rosa COO Jennifer Champoux disposes of 2,175 shares for $43,500

Reuters
·
May 29

Monte Rosa COO Jennifer Champoux sells 2,176 common shares worth $41,344

Reuters
·
May 27

Insider Shake-Up at Monte Rosa Therapeutics Sparks Investor Buzz

TIPRANKS
·
May 23

Monte Rosa director Anthony Manning disposes 10,000 shares worth $180,100

Reuters
·
May 23

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 20